Table 9.
Costs of managing metastatic disease
| Quantity p.a | Price/unit (€) | Total costs p.a. (€) | |
|---|---|---|---|
|
Responsive |
|
|
|
|
Out-patient |
|
|
|
| Specialist practitioner |
4 |
See above |
128.28 |
|
Medication |
|
|
|
| LHRH Agonist leuprorelin |
4 |
415 |
1,660 |
|
Refractory |
|
|
|
|
Medication |
|
|
|
| Docetaxel |
17.3 |
1768 |
30,645.3 |
| Prednisolon |
0.87 |
10.6 |
9.2 |
|
Bone metastases |
|
|
|
|
Out-patient |
|
|
|
| Radiation |
14 |
See Table 5 |
1,484.06 |
|
In-patient |
|
|
|
| Bone scan |
0.7 |
1629.65 |
1,140.76 |
|
Medication |
|
|
|
| Zoledron acid | 12 | 367.98 | 4,415.76 |
LHRH = Luteinizing Hormone-Releasing Hormone.